Abstract:SIRT7 promotes HCC proliferation by regulating YAP activation; SIRT7 downregulates the expression of MST1 through transcriptional and post‐translational regulation and promotes YAP nuclear localization and transcriptional activity; downregulation of SIRT7 can inhibit the occurrence of liver cancer by preserving Hippo signal. Abnormal activation of the oncogene YAP in the Hippo pathway is a major feature in liver cancer and inactivation of MST1/2 has been shown to be responsible for the overactivation of YAP that led to tumorigenesis. However, mechanisms underlying MST1/2 dysregulation remain poorly understood. RNA‐seq analysis and genome (KEGG) pathway enrichment analysis were used to identify genes and pathways that were regulated by SIRT7. qRT‐PCR, ChIP, and luciferase assay were used to investigate transcriptional regulation. Mass spectrometry, co‐immunoprecipitation and immunoprecipitation were used to exam protein–protein interaction and post‐transcriptional modification. A xenograft mouse model was used to confirm the effect of SIRT7 and SIRT7 inhibitors on hepatocellular carcinoma (HCC) proliferation in vivo. We found that SIRT7 suppresses MST1 by both transcriptional regulation and post‐transcriptional modification, which in turn promotes YAP nuclear localization and transcriptional activation in liver cancer. Mechanistically, we revealed that SIRT7 suppresses MST1 transcription by binding to the MST1 promoter and inducing H3K18 deacetylation in its promoter region. In addition, SIRT7 directly binds to and deacetylates MST1, which primes acetylation‐dependent MST1 ubiquitination and protein degradation. In clinical samples, we confirmed a negative correlation between SIRT7 and MST1 protein levels, and high SIRT7 expression correlated with elevated YAP expression and nuclear localization. In addition, SIRT7 specific inhibitor 2800Z sufficiently inhibited HCC growth by disrupting the SIRT7/MST1/YAP axis. Our data thus revealed the previously undescribed function of SIRT7 in regulating the Hippo pathway in HCC and further proved that targeting SIRT7 might provide novel therapeutic options for the treatment of liver cancer.

SIRT7 affects autophagy and activation of hepatic stellate cells by regulating the acetylation level of high mobility group protein 1

HMGB1-induced Autophagy Facilitates Hepatic Stellate Cells Activation: a New Pathway in Liver Fibrosis

SIRT7 protects against liver fibrosis by suppressing stellate cell activation via TGF-β/SMAD2/3 pathway

Sirt6 Alleviated Liver Fibrosis by Deacetylating Conserved Lysine 54 on Smad2 in Hepatic Stellate Cells

MicroRNA-146b Regulates Hepatic Stellate Cell Activation Via Targeting of KLF4.

Inhibition of SIRT1 Relieves Hepatocarcinogenesis Via Alleviating Autophagy and Inflammation

SIRT6 Protects Against Liver Fibrosis by Deacetylation and Suppression of SMAD3 in Hepatic Stellate CellsSummary

SIRT6 Protects Against Liver Fibrosis by Negatively Regulating YAP/TAZ

SIRT6 Protects Against Liver Fibrosis by Deacetylation and Suppression of SMAD3 in Hepatic Stellate Cells

miR-96-5p prevents hepatic stellate cell activation by inhibiting autophagy via ATG7

Sirtuin 6 Protects Against Hepatic Fibrogenesis by Suppressing the YAP and TAZ Function.

Activating SIRT1 deacetylates NF-κB p65 to alleviate liver inflammation and fibrosis via inhibiting NLRP3 pathway in macrophages

Silent Information Regulator 1 (SIRT1) Ameliorates Liver Fibrosis Via Promoting Activated Stellate Cell Apoptosis and Reversion

Transcriptional repression of SIRT1 by protein inhibitor of activated STAT 4 (PIAS4) in hepatic stellate cells contributes to liver fibrosis

Histone methyltransferase Suv39h1 regulates hepatic stellate cell activation and is targetable in liver fibrosis

Activation of the Mir-34A/sirt1/p53 Signaling Pathway Contributes to the Progress of Liver Fibrosis Via Inducing Apoptosis in Hepatocytes but Not in HSCs.

SIRT7 promotes Hippo/YAP activation and cancer cell proliferation in hepatocellular carcinoma via suppressing MST1

LncRNA-SNHG7/miR-29b/DNMT3A Axis Affects Activation, Autophagy and Proliferation of Hepatic Stellate Cells in Liver Fibrosis.

SIRT3 regulates mitophagy in liver fibrosis through deacetylation of PINK1/NIPSNAP1

Repression of Smad7 Mediated by Dnmt1 Determines Hepatic Stellate Cell Activation and Liver Fibrosis in Rats

Lipopolysaccharide mediates hepatic stellate cell activation by regulating autophagy and retinoic acid signaling.